Journal Article

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant

Reedoy, Kajal, van Deventer, Cindy, Stock, Nadine, Manickchund, Nithendra, Mahlangu, Boitshoko, von Gottberg, Anne, Baig, Zainab, Jackson, Laurelle, Abdool Karim, Salim S., Neher, Richard A., Kekana, Dikeledi, Mnguni, Anele, Ntozini, Buhle, Lessells, Richard J., Römer, Cornelius, Karim, Farina, Wolter, Nicole, Marshall, Terry, Jule, Zesuliwe, Bernstein, Mallory, Lustig, Gila, de Oliveira, Tulio, Karim, Quarraisha Abdool, Nzimande, Ayanda, Sigal, Alex, Khan, Khadija, Ganga, Yashica, Gosnell, Bernadett I., Moosa, Mahomed-Yunus S.

2023

Overview

Omicron BA.2.86 subvariant differs from Omicron BA.2 as well as recently circulating variants by over 30 mutations in the spike protein alone. Here we report on the isolation of the live BA.2.86 subvariant from a diagnostic swab collected in South Africa which we tested for escape from neutralizing antibodies and viral replication properties in cell culture. We found that BA.2.86 does not have significantly more escape relative to Omicron XBB.1.5 from neutralizing immunity elicited by either Omicron XBB-family subvariant infection or from residual neutralizing immunity of recently collected sera from the South African population. BA.2.86 does have extensive escape relative to ancestral virus with the D614G substitution (B.1 lineage) when neutralized by sera from pre-Omicron vaccinated individuals and relative to Omicron BA.1 when neutralized by sera from Omicron BA.1 infected individuals. BA.2.86 and XBB.1.5 show similar viral infection dynamics in the VeroE6-TMPRSS2 and H1299-ACE2 cell lines. We also investigate the relationship of BA.2.86 to BA.2 sequences. The closest BA.2 sequences are BA.2 samples from Southern Africa circulating in early 2022. Similarly, many basal BA.2.86 sequences were sampled in Southern Africa. This suggests that BA.2.86 potentially evolved in this region, and that unobserved evolution led to escape from neutralizing antibodies similar in scale to recently circulating strains of SARS-CoV-2. The Omicron BA.2.86 subvariant differs from previous variants by over 30 spike mutations. Here, the authors report that BA.2.86 likely evolved in Southern Africa and that its immune escape is not larger than recently circulating SARS-CoV-2 strains. Neither its replication nor its pathogenicity are enhanced in vitro.

• Publisher: Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
• Subject: 13 / 13/1 / 13/106 / 14 / 631/181/757 / 631/326/596/2554 / 631/326/596/4130 / ACE2 / Africa, Southern / Angiotensin-converting enzyme 2 / Antibodies / Antibodies, Neutralizing / Antibodies, Viral / Cell culture / Cell lines / COVID-19 / COVID-19 - virology / Evolution / Humanities and Social Sciences / Humans / Immunity / multidisciplinary / Mutation / Neutralization / Neutralizing / Pathogenicity / Pathogens / Replication / SARS-CoV-2 - genetics / Science / Science (multidisciplinary) / Severe acute respiratory syndrome coronavirus 2 / Spike protein / Strains (organisms) / Viral diseases / Viral infections